Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS).

Everitt MD, Donaldson AE, Stehlik J, Kaza AK, Budge D, Alharethi R, Bullock EA, Kfoury AG, Yetman AT.

J Heart Lung Transplant. 2011 Apr;30(4):395-401. doi: 10.1016/j.healun.2010.09.008. Epub 2010 Oct 29.

PMID:
21036067
2.

Heart transplantation for adults with congenital heart disease: analysis of the United network for organ sharing database.

Patel ND, Weiss ES, Allen JG, Russell SD, Shah AS, Vricella LA, Conte JV.

Ann Thorac Surg. 2009 Sep;88(3):814-21; discussion 821-2. doi: 10.1016/j.athoracsur.2009.04.071.

PMID:
19699904
3.

Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices.

Gelow JM, Song HK, Weiss JB, Mudd JO, Broberg CS.

J Heart Lung Transplant. 2013 Nov;32(11):1059-64. doi: 10.1016/j.healun.2013.06.024. Epub 2013 Aug 6.

4.

Perioperative mortality is the Achilles heel for cardiac transplantation in adults with congenital heart disease: Evidence from analysis of the UNOS registry.

Shah DK, Deo SV, Althouse AD, Teuteberg JJ, Park SJ, Kormos RL, Burkhart HM, Morell VO.

J Card Surg. 2016 Dec;31(12):755-764. doi: 10.1111/jocs.12857. Epub 2016 Oct 5.

PMID:
27709686
5.

Isolated heart transplant and combined heart-liver transplant in adult congenital heart disease patients: Insights from the united network of organ sharing.

Bradley EA, Pinyoluksana KO, Moore-Clingenpeel M, Miao Y, Daniels C.

Int J Cardiol. 2017 Feb 1;228:790-795. doi: 10.1016/j.ijcard.2016.11.121. Epub 2016 Nov 10.

PMID:
27888756
6.

A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation.

Karamlou T, Hirsch J, Welke K, Ohye RG, Bove EL, Devaney EJ, Gajarski RJ.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):161-8. doi: 10.1016/j.jtcvs.2010.03.036.

7.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037. Epub 2010 May 5.

8.

Heart transplant outcomes in patients with left ventricular non-compaction cardiomyopathy.

Al-Kindi SG, El-Amm C, Ginwalla M, Hoit BD, Park SJ, Oliveira GH.

J Heart Lung Transplant. 2015 Jun;34(6):761-5. doi: 10.1016/j.healun.2014.11.005. Epub 2014 Nov 8.

PMID:
25572453
9.

Should stable UNOS Status 2 patients be transplanted?

Jimenez J, Bennett Edwards L, Higgins R, Bauerlein J, Pham S, Mallon S.

J Heart Lung Transplant. 2005 Feb;24(2):178-83.

PMID:
15701434
10.

Outcome of children with end-stage congenital heart disease waiting for cardiac transplantation.

Mital S, Addonizio LJ, Lamour JM, Hsu DT.

J Heart Lung Transplant. 2003 Feb;22(2):147-53.

PMID:
12581762
12.

Heart transplant vs left ventricular assist device in heart transplant-eligible patients.

Williams ML, Trivedi JR, McCants KC, Prabhu SD, Birks EJ, Oliver L, Slaughter MS.

Ann Thorac Surg. 2011 May;91(5):1330-3; discussion 1333-4. doi: 10.1016/j.athoracsur.2011.01.062. Epub 2011 Mar 24.

PMID:
21439545
13.

Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.

Weiss ES, Nwakanma LU, Patel ND, Yuh DD.

J Heart Lung Transplant. 2008 Feb;27(2):184-91. doi: 10.1016/j.healun.2007.11.566.

PMID:
18267225
14.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
15.
16.

Device therapy for heart failure.

Boehmer JP.

Am J Cardiol. 2003 Mar 20;91(6A):53D-59D. Review.

PMID:
12670643
17.

The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry.

Patlolla V, Patten RD, Denofrio D, Konstam MA, Krishnamani R.

J Am Coll Cardiol. 2009 Jan 20;53(3):264-71. doi: 10.1016/j.jacc.2008.08.070.

18.

Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status?

Winkel E, Kao W, Fisher SG, Heroux AL, Johnson MR, Costanzo MR.

J Heart Lung Transplant. 1998 Aug;17(8):809-16.

PMID:
9730431
19.

Does the UNOS heart transplant allocation system favor men over women?

Hsich EM, Starling RC, Blackstone EH, Singh TP, Young JB, Gorodeski EZ, Taylor DO, Schold JD.

JACC Heart Fail. 2014 Aug;2(4):347-55. doi: 10.1016/j.jchf.2014.03.008. Epub 2014 Jul 9.

20.

Left ventricular assist devices as bridge to heart transplantation: The Niguarda Experience.

Vitali E, Lanfranconi M, Bruschi G, Russo C, Colombo T, Ribera E.

J Card Surg. 2003 Mar-Apr;18(2):107-13.

PMID:
12757336

Supplemental Content

Support Center